Platelet Consumption and Filter Clotting Using Two Different Membrane Sizes during Continuous Venovenous Haemodiafiltration in the Intensive Care Unit
Table 2
Filter longevity and CVVHDF setting.
All patients ()
Filter AV 1000S ()
Filter AV 600S ()
value
Numbers of filters—number
2 (1–4)
2 (1–4)
2 (1–4)
0.94
CVVHDF observation period—hours
35 (7–128)
33 (7–128)
39 (7–97)
0.68
Filter longevity—hours
17 (4–67)
15 (4–67)
21 (4–42)
0.63
Haemodiafiltration rate—mL/kg/h
35 (35–80)
35 (35–50)
35 (35–80)
0.75
Ultrafiltration rate—%
17 (9–24)
17 (12–24)
17 (9–20)
0.90
Blood flow—mL/min
150 (100–240)
150 (100–230)
150 (100–240)
0.50
Heparin dose first 6 hours—U/h
450 (0–1050)
500 (0–1050)
400 (250–900)
0.17
Heparin dose first 6 hours/body weight—U/h/kg
7.1 (0–9.1)
7.3 (0–9.1)
6.7 (3.4–8.6)
0.17
Absolute creatinine drop—umol/L
171 (8–830)
221 (97–562)
157 (8–830)
0.48
Relative creatinine drop—%
64 (7–91)
67 (29–87)
69 (7–91)
0.98
Absolute BUN drop—mmol/L
9.5 (0–30.8)
7.3 (0–30.5)
11 (0–30–8)
0.64
Relative urea drop—%
53 (0–85)
53 (0–77)
54 (0–85)
0.54
Results are given as median (range) or percentages. Total number of patients = 28; filter AV 1000S = 15; filter AV 600S = 13. Total number of patients = 27; filter AV 1000S = 13; filter AV 600 = 14.
